Point72 Asia (Singapore) Pte. Ltd. Sage Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,833 shares of SAGE stock, worth $149,099. This represents 0.05% of its overall portfolio holdings.
Number of Shares
22,833
Previous 20,641
10.62%
Holding current value
$149,099
Previous $112 Million
61.96%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding SAGE
# of Institutions
217Shares Held
49.9MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.2 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.2 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$17.8 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.6 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $388M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...